Filing Flows

Filing Flows › Cartesian Therapeutics (RNAC) › Who owns the stock

Who owns Cartesian Therapeutics (RNAC) stock

88 funds reported Cartesian Therapeutics (RNAC) shares in their latest 13F filings, worth $92.7M in all. The largest holder is Squarepoint Ops LLC ($23.5M). Last quarter 60 funds added to their stakes and 21 cut them.

Largest holders of RNAC (13F)Largest holders of RNAC (13F)Squarepoint Ops LLC$23.5MBlackRock$8.5M683 Capital Management, LLC$6.8MVanguard Capital Management LLC$5.8MVanguard Group$3.9MFMR LLC$3.8MGeode Capital Management, LLC$3.7MAQR Capital Management LLC$3.7MMillennium Management LLC$3.2MTwo Sigma Investments, LP$3.1M

Largest holders (13F)

FundSharesValueChangeQuarter
Squarepoint Ops LLC2,254,619$23.5Mincrease2026-06-30
BlackRock819,239$8.5Mincrease2026-06-30
683 Capital Management, LLC650,000$6.8Mincrease2026-06-30
Vanguard Capital Management LLC555,823$5.8Mincrease2026-06-30
Vanguard Group541,228$3.9Mincrease2025-12-31
FMR LLC368,429$3.8Mdecrease2026-06-30
Geode Capital Management, LLC356,525$3.7Mincrease2026-06-30
AQR Capital Management LLC356,456$3.7Mincrease2026-06-30
Millennium Management LLC309,887$3.2Mincrease2026-06-30
Two Sigma Investments, LP296,293$3.1Mincrease2026-06-30
State Street249,212$2.6Mincrease2026-06-30
Marshall Wace, LLP232,919$2.4Mdecrease2026-06-30
UBS Group AG208,647$2.2Mincrease2026-06-30
Jupiter Topco LLC200,905$2.1Mbase2026-06-30
Privium Fund Management B.V.155,000$1.1Mincrease2026-09-30

Cartesian Therapeutics' latest quarter

Cartesian Therapeutics, Q1 2026: revenue $78K (-93% year over year), net loss $39.2M, operating cash flow −$22.1M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most RNAC stock?

By the latest 13F filings: Squarepoint Ops LLC ($23.5M); BlackRock ($8.5M); 683 Capital Management, LLC ($6.8M); Vanguard Capital Management LLC ($5.8M); Vanguard Group ($3.9M).

What is the short interest in RNAC?

1,875,103 shares were sold short at the 2026-10-15 settlement, 1.05% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.